Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (4.545%)
Market Cap: £195.03m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Proposed Merger

11 Aug 2016 17:30

RNS Number : 9870G
Baronsmead Second Venture Trust PLC
11 August 2016
 

Baronsmead Second Venture Trust plc 

Proposed merger between Baronsmead Second Venture Trust plc and Baronsmead VCT 5 plc (the "Companies")

Introduction

The boards of directors of both the Companies announce that they have entered into discussions regarding a possible merger of the Companies (the "Merger"). It is intended that the Merger would be effected by way of a scheme of reconstruction under the Insolvency Act 1986.

Benefits to shareholders

The boards of the Companies believe that a Merger would be in the best interests of the shareholders of both Companies for the following reasons.

It would result in estimated annual costs savings for the merged company of around £300,000 per annum.

 

It would remove the duplication of communication with the many shareholders that are common to both Companies.

It would create a larger merged company with net assets of approximately £200 million which would mean that the merged company's shares would be more widely available on investment platforms and potentially make it more attractive to private client wealth managers which may enhance the liquidity of the shares in the secondary market.

The proposal

It is proposed that the Merger would be effected by way of a scheme of reconstruction and the winding up of Baronsmead VCT 5 plc under section 110 of the Insolvency Act 1986 (the "Scheme"). Under the terms of the Scheme the assets of Baronsmead VCT 5 plc would be transferred to Baronsmead Second Venture Trust plc (the "Merged Company") in exchange for the issue of new shares in the Merged Company to the shareholders of Baronsmead VCT 5 plc. It is proposed that the costs of the Scheme are shared between the shareholders on a fair basis to ensure that the benefits of the cost savings accrue to all shareholders over the same time period.

Timing

The boards expect to write to their respective shareholders with further details on the terms of the proposed Merger in mid October 2016. It is currently intended that, subject to shareholder approval, the Merger would become effective in late November 2016.

For further information, please contact:

Michael Probin Investor Relations

Livingbridge VC LLP: 020 7506 5796

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQFLFFQVFFBBQ
Date   Source Headline
4th Jun 20263:15 pmRNSNet Asset Value(s)
3rd Jun 202610:15 amRNSNewsletter for the period June 2025 to March 2026
1st Jun 202611:26 amRNSTotal Voting Rights
18th May 20263:45 pmRNSAdmission of Further Securities to Trading
14th May 20262:15 pmRNSAllotment of Shares and Closure of Offer
11th May 20267:00 amRNSNet Asset Value(s)
5th May 20263:15 pmRNSNet Asset Value(s)
1st May 202611:42 amRNSTotal Voting Rights
8th Apr 202610:15 amRNSAdmission of Further Securities to Trading
1st Apr 202611:48 amRNSTotal Voting Rights
31st Mar 20265:37 pmRNSTransaction in Own Shares
30th Mar 20261:50 pmRNSNet Asset Value(s)
24th Mar 20262:25 pmRNSReplacement - Extension to Application Deadline
24th Mar 202612:20 pmRNSApplication Deadline Extension - Fourth Allotment
20th Mar 20267:00 amRNSResult of AGM
11th Mar 20262:00 pmRNSOver-Allotment Facility and Offer Update
5th Mar 20263:30 pmRNSNet Asset Value(s)
2nd Mar 202611:38 amRNSTotal Voting Rights
26th Feb 202612:15 pmRNSAdmission of Further Securities to Trading
20th Feb 202611:02 amRNSDirector/PDMR Shareholding
19th Feb 20264:30 pmRNSAllotment of Shares and Total Voting Rights
17th Feb 20264:05 pmRNSTransaction in Own Shares
6th Feb 202612:06 pmRNSOffer Update:Close of Early Subscription Incentive
5th Feb 20264:15 pmRNSNet Asset Value(s)
2nd Feb 20264:45 pmRNSNet Asset Value(s)
2nd Feb 202610:39 amRNSTotal Voting Rights
29th Jan 20263:35 pmRNSAdmission of Further Securities to Trading
22nd Jan 20263:40 pmRNSAllotment of Shares and Total Voting Rights
12th Jan 202611:35 amRNSPublication of a Supplementary Prospectus
23rd Dec 20257:00 amRNSAnnual Financial Report
23rd Dec 20257:00 amRNSAnnual Financial Report
4th Dec 20253:45 pmRNSNet Asset Value(s)
1st Dec 202510:44 amRNSTotal Voting Rights
20th Nov 20251:22 pmRNSDirector/PDMR Shareholding
20th Nov 202512:00 pmRNSAllotment of Shares and Total Voting Rights
6th Nov 20254:00 pmRNSNet Asset Value(s)
29th Oct 20259:45 amRNSNet Asset Value(s)
13th Oct 20252:00 pmRNSPublication of a Prospectus/Offer for Subscription
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20255:56 pmRNSTransaction in Own Shares
24th Sep 20258:46 amRNSUpdate on Offer for Subscription
23rd Sep 20252:49 pmRNSQuarterly Factsheet June 2025 & Newsletter H2 2025
11th Sep 20256:06 pmRNSTransaction in Own Shares
11th Sep 20255:09 pmRNSDirector/PDMR Shareholding
4th Sep 20253:15 pmRNSNet Asset Value(s)
4th Sep 20258:15 amRNSIntention to Fundraise
6th Aug 20254:15 pmRNSNet Asset Value(s)
31st Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 202510:00 amRNSNet Asset Value(s)
1st Jul 20255:13 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.